A Randomized Controlled Trial on the Efficacy and Safety of a Calcium-Channel Blocker and an Angiotensin-Converting Enzyme Inhibitor in Chinese and European Patients with Hypertension — Wei Zhang (2024) | RDL Network
A Randomized Controlled Trial on the Efficacy and Safety of a Calcium-Channel Blocker and an Angiotensin-Converting Enzyme Inhibitor in Chinese and European Patients with Hypertension
Article 2024 en
Authors
WZ
Wei Zhang
CL
Changyuan Liu
GB
Grzegorz Bilo
Abstract
1 min read
Identifier at clinicaltrials.gov NCT02499822 (Registration date: 16 July 2015).
Jessica C. Levenson, Bruce L. Rollman, Lee M. Ritterband, Patrick J. Strollo, Kenneth J. Smith, Jonathan G. Yabes, Charity G. Moore, Allison G Harvey, Daniel J. Buysse
Víctor Pérez, Ariana Salavert, Jordi Espadaler, Miquel Tuson, Jerónimo Sáiz-Ruiz, Cristina Sáez-Navarro, Julio Bobes, Enrique Baca‐García, Eduard Vieta, J.M. Olivares, Roberto Rodriguez-Jimenez, José María Villagrán Moreno, Josep Gascón, José Cañete, Montse Solé, Pilar A. Sáiz, Ángela Ibáñez, Javier de Diego-Adeliño, José M. Menchón
Edwin Wong, Carla Nester, Teresa Cavero, Alexandre Karras, Moglie Le Quintrec, Liz Lightstone, Ute Eisenberger, María José Soler, David Kavanagh, Erica Daina, Manuel Praga, Nicholas Medjeral‐Thomas, Anja Gäckler, Clara García-Carro, Andrea Biondani, Frédérique Chaperon, Kenneth Kulmatycki, Julie Milojevic, Nicholas J.A. Webb, Prasanna Kumar Nidamarthy, G. Junge, Giuseppe Remuzzi
Discussion(0)
No comments yet. Be the first to comment.